Sony-Zee merger can hurt competition, more scrutiny needed, says Competition Commission of India
The Hindu
With 92 Zee channels in India and Sony’s global revenue of $86 billion, CCI said the deal would place the combined entity in a ‘strong position’
A merger between the Indian unit of Japan’s Sony and Zee Entertainment to create a $10 billion TV enterprise will potentially hurt competition by having “unparalleled bargaining power”, the country’s antitrust watchdog found in an initial review, according to an official notice seen by Reuters.
The Competition Commission of India’s (CCI) August 3 notice to the two companies stated the watchdog is of the view that a further investigation is merited.
Shares in Zee fell nearly 5% in morning trade on Thursday following the Reuters report.
Sony and Zee in December decided to merge their television channels, film assets, and streaming platforms to create a powerhouse in a key media and entertainment growth market of 1.4 billion people, challenging rivals like Walt Disney Co.
The CCI’s findings will delay regulatory approval of the deal and could force the companies to propose changes to its structure, three Indian lawyers familiar with the process said. If that still fails to satisfy the CCI, it could lead to a prolonged approval and investigation process, they added.
Zee in a statement said it continues to take all the required legal steps to complete all the necessary approval processes for the proposed merger.
The CCI and Sony in India did not respond to requests for comment. Representatives of Sony in Japan also did not respond.
Alma Medical Private Limited, the Indian subsidiary of the Israeli manufacturer that’s among the global innovators in lasers for medical, light-based, radiofrequency, and ultrasound solutions in the aesthetic, surgical and beauty (spa) markets, is expanding further into Asia, where it already has a strong presence, especially in India, China, Korea and Japan, apart from Australia.